Mehmet Şengör1, Mustafa Akbulut2, Serpil Taş2, Mesut Şişmanoğlu2

1Department of Cardiovascular Surgery, Bezmialem University Faculty of Medicine, İstanbul, Türkiye
2Department of Cardiovascular Surgery, Koşuyolu Yüksek İhtisas Training and Research Hospital, İstanbul, Türkiye

Keywords: Quality of life; subclavian arteries; thoracic aorta.


Objectives: This study aims to evaluate the clinical outcomes and quality of life of patients with or without the left subclavian artery (LSA) revascularization in patients with thoracic aortic diseases undergoing endovascular repair of the ishimaru zone 2.

Methods: A total of 48 patients with the closure of the LSA after thoracic endovascular aortic repair (TEVAR) were enrolled in the study between 2014 and 2018, of whom 21 had undergone the LSA (revascularization group), and the remaining 27 cases (non-revascularization group). The study was planned as a single-center retrospective design. Data were retrieved from the patients’ files. Short form-36 scales were administered to assess quality of life.

Results: There was no difference between the two groups with and without LSA revascularization in 30-day paraplegia (4.8% vs. 0.0%, p=0.449), 4-year cerebrovascular events (0.0% vs. 3.8%, p=0.998), upper extremity ischemia (9.6% vs. 0.0%, p=0.207), death (28.6% vs. 25.9%, p=0.887), rate of endoleak (23.8% vs. 29.6%, p=0.896), and length of intensive care unit stay (2.3±2.1 days vs. 2.1±1.8 days, p=0.645). Regarding the quality of life, only physical functioning was improved slightly more in the group that underwent LSA without revascularization (90.7±26.7 vs. 82.3±14.9, p=0.032).

Conclusion: The current study showed no significant differences with respect to neurological outcomes, upper extremity ischemia, quality of life, and mortality among patients undergoing TEVAR with or without revascularization of the LSA.

Cite This Article: Şengör M, Akbulut M, Taş S, Şişmanoğlu M. Clinical Outcomes and Quality of Life Following TEVAR with or without Revascularization of the Left Subclavian Artery. Koşuyolu Heart J 2024;27(1):16–21.

Ethics Committee Approval

The study was approved by the University of Health Sciences Kartal Koşuyolu Yüksek İhtisas Training and Research Hospital Non-Interventional Clinical Research Ethics Committee (no: 2018.3/2-94, date: 25/04/2018).

Peer Review

Externally peer-reviewed.

Author Contributions

Concept – M.Ş., M.A., S.T., M.Şi; Design – M.Ş., M.A., S.T., M.Şi; Supervision – M.Ş., M.A., S.T., M.Şi.; Funding – M.Ş.; Materials – M.Ş.; Data collection and/or processing – M.Ş., M.A.; Data analysis and/or interpretation – M.Ş., S.T.; Literature search – M.Ş., M.A.; Writing – M.Ş., M.A.; Critical review – M.Ş., S.T.

Conflict of Interest

All authors declared no conflict of interest.

Use for AI for Writing Assistance

Not declared.

Financial Disclosure

The authors declared that this study received no financial support.